Nevrargenics Ltd
PrivateLast Round
VC Round
Apr 17, 2024
Est. Valuation
$25M
Company Overview
Nevrargenics Ltd is a biotechnology company that specializes in the discovery and development of novel medicines, specifically retinoic acid receptor modulators, for the treatment of neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nevrargenics Ltd Comparables
Compare Nevrargenics Ltd with similar companies based on industry and business-model similarity.
Nevrargenics Ltd Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 17, 2024 | ||||
| Seed | Dec 18, 2019 |
Nevrargenics Ltd Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Aberdeen | Seed |
Nevrargenics Ltd Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nevrargenics Ltd's valuation, stock price, and market status.